JP Morgan analyst Stephen Tusa maintains Fortive (NYSE:FTV) with a Overweight and raises the price target from $60 to $68.
Morgan Stanley Maintains Overweight on IsoPlexis, Lowers Price Target to $12
Morgan Stanley maintains IsoPlexis (NASDAQ:ISO) with a Overweight and lowers the price target from $17 to $12.